BACKGROUND
According to the Organization for Economic Co-operation and Development (OECD), 55% of global wealth is in the knowledge (OECD, 2008) . Drucker (Drucker, 2006) points out that the increase in the generation of this knowledge will occur with the increase of knowledge management.
New trends influence the industrial development of a country, such as the knowledge, like a main resource and the learning, like a central process. Therefore, it is essential to broaden the base of expertise in human resources and hence increasing the innovation potential (Lastres & Sarita, 1999) .
Formation of competencies for innovation requires previously defined as an intelligence cooperative, which translates as construction of knowledge in collaboration with peers at work. This mindset requires collaborative development processes capable of producing high quality information for scientific and technological knowledge. The experts have unrestricted access to information created by the scientific community, collaborative review of the contributions of members, governance based more on authority than on sanctions, and involvement in integrated levels and responsibilities (Ambrosi, Peugeot, & Pimenta, 2005) .
In 1977, Tidd, Pavitt and Bessant discussed innovation as a change in products and services offered by an organization or even a change in the process or in a way to prepare the products or services. It also can be considered the way this organization delivers its products (Tidd, Pavitt, & Bessant, 2005) .
Success of the activities of companies, research groups, government and institutions of countries are effective when they attribute value and quality in their information considered critical. These factors will lead the organization to succeed in their internal and external planning such as strategies for short and long term. Thus, the capital of intellectual property plays an important role in enterprises and knowledge becomes increasingly "key" to competitiveness, technology and so economic development. This happens mainly in the sectors of high density technology where knowledge is considered like the most important asset of the company (Quoniam, 2011) . Therefore, it is essential to invest in Research, Development and Innovation (R,D&I) so that an organization stay active and competitive. Information Science provides Web 2.0 tools that can help in the generation, treatment, storage and data management of any activities or processes, providing a better management system for innovation. Due to market system increasingly turbulent beyond complex and competitive business in which they operate, the use of new approaches such as Intellectual/Industrial Property becomes the guarantee of continuity of their activities (Pierret, 2006 (Quoniam & Lucien, 2010) .
Using this approach is salutary to identify and promote the synergy of these experts to advance science. Thus, the innovation will be achieved through technological development in certain areas. Linking this statement with the approach of this work is expected to contribute in the management area to improving the treatment, alerts and ways for diseases' eradication (Magalhães, Boechat, & Antunes, 2012a) . Therefore, from the democratization of knowledge provided by the Web 2.0 tools using open access, it is possible to demonstrate the use of indicators for nonspecialists democratized.
One footstep can be observed in figure 1 , a global health map that brings together disparate data sources, including online news aggregators, eyewitness reports, expert-curated discussions and validated official reports, to achieve a unified and comprehensive view of the current global state of infectious diseases and their effect on human and animal health. Each point on the map indicates, in accordance with the color intensity, the highest or the lowest level of a certain disease. Another example is analysis in information from patents that can be incorporated into the competitive technological strategy of companies in a great variety of ways. It serves as an indicator of future developments in technology and gives your own company a decisive lead in its actions. WHO estimates that there are about 1 billion people suffering some ND. However, the challenge is best understood when we think of neglected populations, i.e., include not only new treatments for ND, but also access to antimicrobials, affordable medicines for diseases with global impact as diabetes and cancer (Moon, Bermudez, & 't Hoen, 2012) .
Among these diseases forgotten by the pharmaceutical industry, exemplify the tuberculosis (TB). This illness is a global affliction, and the WHO estimates that it affects 2 billion people, which means that a third of the world's population is infected with the bacillus Mycobacterium tuberculosis (M.tb) (see figure 2). The bacillus is capable of lying dormant in a human body for years until an individual's immunity system becomes unable to ward off the infection and incapable of destroying the bacillus. While the majority of people with the latent infection never develop the active form of the disease, between 5% and 10% of the carriers will be afflicted by it during their lives. Over 95% of TB deaths occur in low-and middle-income countries, and it is among the top three causes of death for women aged 15 to 44. In 2011 alone it is estimated that globally over 1.4 million people died as a direct result of tuberculosis while another 8.7 million developed the active form of the disease ("WHO | Tuberculosis", 2012). Although in some parts of the world incidence rates are falling, in those where poverty is prevalent and HIV/AIDS rates are high the disease has maintained a continuous growth rate, and it is the principal infectious disease responsible for AIDS/HIV mortalities. This global pandemic disease is deepening the chasm which separates rich and poor countries and further accentuating global social stress. For example, in 2009 alone, almost 10 million children were orphaned by parental mortalities caused by tuberculosis (Vasconcellos & Morel, 2012) . Accordingly, use the Web 2.0 tools for help innovation management in health global, mainly ND seems a good way for no-developed countries and other threatened by such disease.
METHODS
This work is descriptive, accomplished through databases available on the web. So, Property Organization (WIPO) and HealthMap -the data were processed at the own base and later analyzed, as well as patents analysis.
DISCUSSION
Need better management of information from the "Knowledge Age" and the technology involved. Should be considered adaptation to actual conditions of each local culture and collaboration of R,D&I through collaborative networks for dissemination of knowledge beyond development and innovation. Work with Information Science for whatever application area comprises a highly structured network (Le Moigne, 1994; Quoniam & Lucien, 2010) . Since the processes involved in R,D&I drugs are increasingly complex, there is a need to train multidisciplinary teams in order to establish a systemic view (Ferreira et al., 2013) . 191,981 scientific papers have been published related to TB. The five largest producers are the USA with 7.4%, India (3.5%), UK (2.5%), Japan (2.2%) and China (1.6%). Brazil appears 11th
in the ranking with 0.9% of the total -1,680 papers (see figure 5 ). Although the USA is leading in the polls when looking for cities, London is the main with 2.379 papers publications. Trends evaluation through patents evolution is a strong indicator of R,D&I (Antunes & Magalhães, 2008 Figure 6 shows the distribution by countries and groups PCT and EPO.  Pioneer country in research by specialists is the same what else inserts patents in the area (USA) followed by the BRIC countries (Brazil, Russia, India and China).
